We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin (SAIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01628445
Recruitment Status : Terminated (Error made by local pharmacy caused mixed randomization of 20 participants)
First Posted : June 26, 2012
Last Update Posted : January 21, 2016
Novo Nordisk A/S
Information provided by (Responsible Party):
Dr. Vincent Woo, University of Manitoba

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2015
  Study Completion Date : November 2015